Accendra Health Inc
ACH- Exchange
- NYSE
- Industry
- Wholesale-Medical, Dental & Hospital Equipment & Supplies
- SEC CIK
- 0000075252
In the last 90 days, Accendra Health Inc insiders filed 0 open-market purchases and 1 sale; 117 institutions reported holding it in 13F filings for Q3 2026, worth $34.4M in total; no superinvestor holds it.
Other share classesACCH
Key figures
- Market capClose on Nov 16, 2026
- $6.59M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $4.05K in total
- 1
- 13F holdersQ3 2026, −22 vs. previous quarter
- 117
- 13F valueReported value at the end of Q3 2026
- $34.4M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $2.76B
- −74.2% year over year
- Net income, FY2025
- -$1.10B
- No comparable prior period
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q3 FY2026
- $601.8M
- −13.7% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $1.10B (39.8% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 10.1M
- Shares sold short
- Change
- +1.03M
- +11.3% vs. previous
- Days to cover
- 4.05
- At average daily volume
Superinvestors holding ACH, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding ACH at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Accendra Health Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 (view filing)4:03 PM ET | Nov 16 | 1 day | Bernocchi Perry AOther: former Chief Operating Officer | SSale | −33.2K | $0.122 | −$4.05K | −10.6%280.8K after | 10b5-1 |
| Aug 14, 2025 (view filing)8:23 PM ET | Aug 12 | 2 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchaseCommon Stock, par value $2 per share ("Common Stock") | +720.0K | $5.15 | +$3.71M | +6.2%12.3M after | |
| Aug 14, 2025 (view filing)8:23 PM ET | Aug 13-14 | 1 day | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchase | +817.9K | $5.37 | +$4.39M | +6.7%13.1M after | 2 lots |
| Apr 10, 2025 (view filing)9:43 PM ET | Apr 8 | 2 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchaseCommon Stock, par value $2 per share ("Common Stock") | +105.0K | $7.96 | +$835.8K | +0.9%11.3M after | |
| Apr 10, 2025 (view filing)9:43 PM ET | Apr 9-10 | 1 day | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchase | +305.0K | $7.34 | +$2.24M | +2.7%11.6M after | 2 lots |
| Apr 7, 2025 (view filing)8:21 PM ET | Apr 3 | 4 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchaseCommon Stock, par value $2 per share ("Common Stock") | +160.0K | $8.53 | +$1.36M | +1.5%10.8M after | |
| Apr 7, 2025 (view filing)8:21 PM ET | Apr 4-7 | 3 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchase | +368.4K | $7.94 | +$2.93M | +3.4%11.2M after | 2 lots |
| Mar 4, 2025 (view filing)9:07 PM ET | Feb 28 | 4 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchaseCommon Stock, par value $2 per share ("Common Stock") | +1.74M | $9.39 | +$16.3M | +22.5%9.47M after | |
| Mar 4, 2025 (view filing)9:07 PM ET | Mar 3-4 | 1 day | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchase | +1.15M | $9.58 | +$11.1M | +12.2%10.6M after | 2 lots |
| Nov 25, 2024 (view filing) | Nov 21 | 4 days | Leon Jonathan AEVP, Chief Financial Officer | SSale | −5.28K | $11.82 | −$62.4K | −3.9%130.8K after | 10b5-1 |
Top 10 13F holders, Q3 2026
See all 117 holdersThe largest institutional positions in Accendra Health Inc at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Coliseum Capital Management, LLC | 13,100,807 | $7.37M | 0.75% | 00.0% | Unchanged |
| Bank of America Corp | 8,270,487 | $4.65M | 0.00% | +4,494,962+119.1% | Added |
| BlackRock, Inc. | 5,335,327 | $3.00M | 0.00% | −168,775−3.1% | Reduced |
| Paradigm Capital Management Inc | 3,952,200 | $2.22M | 0.07% | +1,415,501+55.8% | Added |
| Vanguard Capital Management LLC | 3,087,931 | $1.74M | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 2,720,768 | $1.53M | 0.00% | −360,639−11.7% | Reduced |
| Marshall Wace, LLP | 2,507,586 | $1.40M | 0.00% | −74,993−2.9% | Reduced |
| Charles Schwab Investment Management Inc | 1,783,935 | $1.00M | 0.00% | −1,104,123−38.2% | Reduced |
| Dana Investment Advisors, Inc. | 1,713,671 | $964.3K | 0.03% | −230,936−11.9% | Reduced |
| Geode Capital Management, LLC | 1,612,165 | $907.5K | 0.00% | −260,962−13.9% | Reduced |
Holders of 5% or more of ACH
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Accendra Health Inc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Coliseum Capital Management, LLC | 13D | 16.90%13.1M shares | +1.80 ppfrom 15.10% | Dec 27, 20244 filings | Nov 14, 2025 | SEC |
| Bank of America Corp | 13G | 10.80%8.27M shares | New | Oct 7, 20261 filing | Oct 7, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 7.10%5.45M shares | −7.60 ppfrom 14.70% | Apr 30, 20252 filings | Oct 2, 2025 | SEC |
| Webb Kevin Michael | 13G | 5.61%4.29M shares | New | Mar 30, 20261 filing | Mar 30, 2026 | SEC |
| Paradigm Capital Management Inc | 13G | 5.10%3.95M shares | New | Nov 12, 20261 filing | Nov 12, 2026 | SEC |